Clinical trial
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg…
NCT00004228 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00004228 |
|---|---|
| Title | Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma |
| Official title | Randomized Phase III Study for the Treatment of Newly Diagnosed Disseminated Lymphoblastic Lymphoma or Localized Lymphoblastic Lymphoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, leucovorin calcium, mercaptopurine, methotrexate, prednisone and 3 more |
| Enrollment | 393 |
| Start date | Jun 1, 2000 |
| Primary completion | Aug 1, 2008 |
| Completion | Mar 31, 2015 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 6, 2019 |
| Countries | Australia, Canada, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: